Parvovirus B19 viremia in children with systemic lupus erythematosus

被引:0
作者
El-Saadany, Hosam F. [1 ]
Talat, Mohamed A. [1 ]
Salah, Hosam E. [1 ]
机构
[1] Zagazig Univ, Dept Pediat & Clin Pathol, Zagazig, Egypt
来源
EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY | 2011年 / 9卷 / 02期
关键词
Human parvovirus B19; Systemic lupus erythematosus; Nested PCR;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Parvovirus B19 infection may present with fever, rash, non-erosive arthritis, hepatitis, anemia, thrombocytopenia, leucopenia and positive ANA, B19 infection may be misdiagnosed as new onset systemic lupus erythematosus. At the same time, B19 infection and systemic lupus erythematosus may occur simultaneously in some patients. A casual relationship between B19 infection and classic idiopathic systemic lupus erythematosus has not been demonstrated yet. Objectives: This study was undertaken to investigate the seroprevalence of parvovirus B19 in SLE patients and to search for the different correlates of this viremia with positive results. Methods: This case-control study was conducted on 30 patients with SLE and 30 normal controls. All the children were subjected to detailed medical history, Clinical examination, laboratory estimation as sera from them were examined for parvovirus B19 infection by serological assays using nested polymerase chain reaction and IgG and IgM antiB19 antibodies by ELISA. Results: Parvovirus B19 DNA was detected in 11 of the 30 patients with SLE (33.3 percent) while it was not detected in any of our normal controls. Of the 11 patients with B19 DNA, only two had IgG anti-B19 antibody and one had IgM anti-B19 antibodies, whereas IgG and IgM anti-B19 antibodies were detected in 11(57.8%) and 9 (47.3%) of 19 SLE patients without B19 DNA respectively. B19 DNA was found more commonly in sera from SLE patients without anti-B19 antibodies than in those with anti-B19 antibodies (P < 0.05). Conclusions: parvovirus B19 might induce either idiopathic SLE in a person who is genetically susceptible or it might induce a SLE-like picture. Parvovirus B19 infection in patients with SLE may be due to lack of anti-B19 antibodies because of either the immunocompromised nature of the host or the use of immunosuppressive drugs. There was a higher prevalence of hypocomplementemia in patients with parvovirus B19 viremia than in those without parvovirus.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 50 条
  • [21] Parvovirus B19 induced lupus-like syndrome with nephritis
    Georges, Elodie
    Rihova, Zuzana
    Cmejla, Radek
    Decleire, Pierre-Yves
    Langen, Corinne
    ACTA CLINICA BELGICA, 2016, 71 (06) : 423 - 425
  • [22] LUPUS-LIKE PRESENTATION OF HUMAN PARVOVIRUS B19 INFECTION
    KALISH, RA
    KNOPF, AN
    GARY, GW
    CANOSO, JJ
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (01) : 169 - 171
  • [23] Emerging lupus-like manifestations in acute parvovirus B19 infection
    Toshiro Sugimoto
    Atsuko Tsuda
    Takashi Uzu
    Atsunori Kashiwagi
    Clinical Rheumatology, 2008, 27 : 119 - 120
  • [24] Emerging lupus-like manifestations in acute parvovirus B19 infection
    Sugimoto, Toshiro
    Tsuda, Atsuko
    Uzu, Takashi
    Kashiwagi, Atsunori
    CLINICAL RHEUMATOLOGY, 2008, 27 (01) : 119 - 120
  • [25] Parvovirus B19 in Rheumatic Diseases
    Arvia, Rosaria
    Stincarelli, Maria A.
    Manaresi, Elisabetta
    Gallinella, Giorgio
    Zakrzewska, Krystyna
    MICROORGANISMS, 2024, 12 (08)
  • [26] Parvovirus B19 and immune disorders
    Pugliese, Agostino
    Beltramo, Tiziana
    Torre, Donato
    Roccatello, Dario
    CELL BIOCHEMISTRY AND FUNCTION, 2007, 25 (06) : 639 - 641
  • [27] Parvovirus B19 and autoimmune diseases
    Meyer, O
    JOINT BONE SPINE, 2003, 70 (01) : 6 - 11
  • [28] PARVOVIRUS INFECTION MIMICKING SYSTEMIC LUPUS-ERYTHEMATOSUS
    NESHER, G
    OSBORN, TG
    MOORE, TL
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1995, 24 (05) : 297 - 303
  • [29] Human parvovirus B19 infection in children: Uncommon clinical presentations
    Barash, J
    Dushnitzky, D
    Sthoeger, D
    Bardenstein, R
    Barak, Y
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (10): : 763 - 765
  • [30] Refractory liver dysfunction was remarkably improved with chelating agents of Wilson's disease, in a patient with systemic lupus erythematosus-like syndrome after a parvovirus B19 infection
    Nameki, Shinichiro
    Maeda, Yuichi
    Shibahara, Takayuki
    Fukui, Jun
    Shimizu, Takeshi
    Bessho, Kazuhiko
    Fujiwara, Hiroshi
    MODERN RHEUMATOLOGY CASE REPORTS, 2021, 5 (01) : 182 - 187